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The Netherlands; bResearch Center for Insurance Medicine, AMC-UMCG-UWV-VUmc, The Netherlands; cDepartment of Psychosocial Research
and Epidemiology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; dDepartment of Epidemiology and Biostatistics, VU
University Medical Center, Amsterdam, The Netherlands
ABSTRACT
Background: Up to 53% of cancer survivors (CSs) experiences job loss during or after treatment. To
support CSs with job loss in the Netherlands, a tailored return to work (RTW) program was developed.
The objective of this study was to assess the effectiveness of the program on duration until sustainable
RTW in CSs with job loss.
Material and methods: This study employed a two-armed (intervention/control) randomized con-
trolled design with one-year follow-up. The primary outcome measure was duration until sustainable
RTW. The secondary outcome measures were: rate of RTW, fatigue, quality of life, and participation in
society. Descriptive analyses, Kaplan-Meier estimators and Cox regression analyses were conducted.
Results: Participants (N¼ 171) had a mean age of 48.4 years (SD¼ 8.6). The majority was female (69%)
and breast cancer survivor (40%). The crude hazard ratio (HR) for duration until sustainable RTW was
0.86 (95% CI 0.46–1.62; p¼ 0.642). In the adjusted model, the intervention group had a slight, but stat-
istically non-significant, improvement in duration until sustainable RTW compared to the control group
(HR 1.16; 95% CI 0.59–2.31; p¼ 0.663). The program did not have any significant effects on secondary
outcome measures.
Conclusion: As the tailored RTW program did not demonstrate a statistically significant effect on dur-
ation until sustainable RTW in CSs with job loss, implementation of the program in its current form is
not recommended.
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Among the many challenges in cancer survivorship are long-
term or permanent physical and mental health problems,
which often occur as a result of diagnosis and treatment [1,2].
For example, cancer survivors (CSs) may experience fatigue,
pain and cognitive problems, long after treatment has been
completed [3]. Studies have shown that these health problems
may greatly affect CSs’ daily functioning and quality of life [4].
Moreover, for CSs in the working age, impairments in physical
and mental health may reduce chances of participation in
work [5]. For example, up to 53% of CSs become unemployed,
either by job loss or quitting work, in the first six years after
diagnosis [6]. Moreover, across studies, CSs are 1.4 times more
likely to be unemployed than healthy persons [7]. Although
64% of CSs return to work (RTW) eventually, studies show that
many CSs struggle with it [6].
Furthermore, due to the increase in flexible employment
in Western economies, more workers on long-term sick leave,
including CSs, are vulnerable to job loss [8]. To illustrate the
increase of flexible employment in the Netherlands, there
was an increase of 20% in the number of persons working
with a temporary contract in 2015, compared to 2008 [9].
A recent Dutch report showed that workers in temporary
employment may experience job loss after being diagnosed
with cancer, as Dutch employers are generally not inclined to
prolong the temporary employment contracts of these work-
ers [10]. For CSs who experience job loss, the process of RTW
can be more complicated, compared to CSs who still have an
employment contract, facing a large distance to the labor
market, potential employer stigmatization during job inter-
views and no access to support from employer and col-
leagues [11]. Therefore, CSs who have experienced job loss
may be in need for tailored RTW support.
The importance of RTW support for CSs with job loss is
further stressed by insurance physicians, working at the
Dutch Social Security Agency (SSA), where they provide med-
ical consultation and assess work ability. In the Netherlands,
the SSA is responsible for persons who become unemployed
before or during sick leave, for example due to cancer [12].
The SSA takes over the role of the former employer in the
case of job loss, by providing substituted income in the form
of sickness or disability benefits. The SSA also provides RTW
guidance through the services of re-integration experts, labor
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experts and insurance physicians [12]. Both insurance physi-
cians and CSs with job loss have previously reported that the
SSA’s usual care, including RTW guidance, is not suited to
the specific RTW needs of CSs with job loss [11].
In order to meet the need for adequate RTW support in
CSs with job loss, from 2011 onward, the SSA cooperated with
the VU University Medical Center to develop and evaluate a
tailored RTW program. From 2013 to 2015, the RTW program
was offered to CSs with job loss in the Netherlands, on a
national level [13]. We hypothesized that offering a tailored
return to work program to CSs with job loss would lead to a
significant improvement in duration until RTW in these CSs,
compared to the usual care that is currently provided by the
SSA. The purpose of this study was to test this hypothesis and
assess the effectiveness of the tailored RTW program on dur-
ation until sustainable RTW for CSs with job loss.
Material and methods
Design
In this randomized controlled trial (RCT), the effectiveness of
a tailored RTW program on duration until sustainable RTW
was assessed in a population of sick-listed CSs with job loss.
The RTW program was offered in a two-armed (intervention
and control), non-blinded RCT, with a follow-up period of 12
months. The intervention group received the program, as
well as usual care by professionals from the SSA. The control
group only received the usual care from the SSA. The SSA’s
usual care generally consisted of a few meetings per year
with an insurance physician, and potentially also a labor mar-
ket or re-integration expert. The aim of these meetings was
to discuss or evaluate work ability and opportunities for RTW.
In that way, these meetings were somewhat comparable to
meetings between a sick-listed employee and an occupa-
tional physician of his/her company. In general, usual care
from the SSA does not involve any type of re-integration or
supportive intervention program. As the study protocol of
the RCT has been published previously, a summary of the
study procedures is provided here [13]. This study has been
approved by the Medical Ethical Committee of the VU
University Medical Center, Amsterdam, The Netherlands. The
RCT is registered in the Dutch Trial Register, registration
number NTR3652.
Study population and sample size
The population of this study consisted of CSs who had expe-
rienced job loss. Most CSs in this population experienced job
loss after diagnosis, because their temporary employment
contract expired during/after treatment, and was not
renewed. Additionally, some CSs experienced job loss before
diagnosis, and were receiving unemployment benefits at
time of diagnosis. After diagnosis, their unemployment
benefits were changed to sickness benefits, and they became
part of the population of CSs with job loss, registered at the
SSA. In order to participate in this study, CSs with job loss
had to be registered at the SSA as: sick-listed, receiving sick-
ness or disability benefits due to cancer, without
employment, and of working age, i.e., 18–60 years.
Specifically, CSs were selected who were on sick leave for at
least 12 months and maximum 36 months. The 12-month
cutoff was chosen in accordance with the Dutch social secur-
ity system, in which CSs’ eligibility for sickness benefits is
reevaluated at 12 months. The 36-month cutoff was chosen
because of limited availability of reliable data in the SSA
registries, past three years of sick leave. Further, CSs had to
have completed intensive cancer treatment at least six weeks
before inclusion, and had to feel healthy enough to
potentially participate in the RTW program (based on CSs’
self-report). Additionally, the CS’s general physician was con-
tacted after inclusion in the study to verify that the CS had
no comorbidities that would interfere with participation. CSs
were excluded if they, among other factors, were diagnosed
with metastasized cancer, were pregnant, did not speak flu-
ent Dutch, or if they had signed up to participate in a con-
current program or study. After trial commencement, an
amendment was approved by the Medical Ethical Committee
of the VU University Medical Center to also include CSs with
metastasized cancer in the study. This amendment was moti-
vated by comments from CSs with metastasized cancer in
the inclusion process, who were motivated and able to par-
ticipate, and by advice obtained from the Dutch cancer
patient movement.
Recruitment
Recruitment was organized both retrospectively and pro-
spectively from April 2013 to January 2015. Retrospectively,
all CSs who met the inclusion criteria were identified in the
SSA registries, and invited to participate. Prospectively, CSs
who reached the 12-month threshold were identified every
other week, and invited to participate. Eligible CSs received
an invitational package via postal mail. The package included
an information letter, an information leaflet, a screening
questionnaire with an informed consent form, a postcard,
and a letter from the chief medical officer of the SSA,
explaining and supporting the study, and stating that CSs
were under no obligation to participate.
CSs who were not interested in participating could use
the postcard to inform the researchers of their decision. On
the postcard, they could provide motives for declining par-
ticipation, e.g., ‘I have already found a new job’ or ‘Due to
physical problems, I am not ready to RTW yet’. Also, CSs
could use the postcard to postpone the invitation to par-
ticipate, i.e., they could list a new date on which they
would like to be re-invited for the study. CSs who were
interested to participate could complete the screening
questionnaire and informed consent form, and return these
to the researchers. If the CS was eligible to participate,
based on the screening questionnaire, (s)he was contacted
by telephone to verify if the inclusion criteria for the study
were met. Also, additional information regarding the RCT
was provided by phone. The CS then received the baseline
questionnaire and a second informed consent form for par-
ticipation in the RCT. After these forms were returned, the
CS was included in the study and randomization was
performed.
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Randomization
After inclusion in the study, participants were randomly allo-
cated to the intervention or the control group, using ran-
domization software. The first step in the randomization
procedure was to identify the participant’s stratum, based on
the employment situation prior to the participant’s sick leave,
as indicated in the screening questionnaire and retrieved
from the SSA registry. As professionals at the SSA indicated
that there could be substantial differences between partici-
pants, because of their previous employment situation, three
different strata were distinguished, i.e., 1) workers whose
temporary employment contract ended during sick leave; 2)
temporary agency workers; and 3) unemployed workers, i.e.,
workers who were in-between jobs and, when diagnosed
with cancer, were transferred within the SSA-system from
unemployment benefits to sickness benefits. Within each
stratum, participants were randomly allocated (block size: 4;
ratio 1:1) to either the intervention or the control group. A
researcher (KB) who was not involved in the inclusion pro-
cess of participants performed the identification of the
appropriate stratum and conducted the randomization pro-
cedure. The outcomes of the randomization procedure were
double-checked by SD.
Tailored RTW program
The tailored RTW program consisted of an introductory inter-
view, a ‘Preparation for RTW’ part, and a ‘RTW’ part.
Throughout the entire program, participants were encour-
aged to actively participate in the development of a consen-
sus-based RTW plan, as well as to participate in coaching
sessions to prepare for RTW, and to explore possibilities for
(therapeutic) RTW. The whole RTW program was tailored in
the sense that participants could select various routes
through the different parts of the program, to match the
required level of RTW support. The program is presented in
Figure 1.
All participants in the intervention group started the tail-
ored RTW program with an introductory interview with a re-
integration coach. In this interview, potential obstacles and
possibilities for RTW were identified, and a route through the
intervention program was chosen. Specifically, it was eval-
uated if the participant was ready to ‘RTW’, or if ‘Preparation
for RTW’ was needed. Also, participant’s expectations and
present activities with regard to RTW were discussed. If par-
ticipants were already actively looking for jobs, they would
start with the ‘RTW’ part (Figure 1: Route 1 in the program).
In this part of the program, participants were placed in thera-
peutic or paid work with the support of two job hunting
agencies. The two job hunting agencies who delivered the
‘RTW’ part employed mostly vocational therapists or person-
nel with a background in human resource management.
They had no specific expertise with regard to cancer. The job
hunting agencies had multiple locations across the
Netherlands. Participants traveled to the local office nearest
to them.
If the conclusion of the introductory interview was that
the participant was not actively involved in RTW activities,
e.g., looking for work, the participant would start with the
‘Preparation for RTW’ part (Route 2 in the program). This part
(developing a RTW plan and coaching) was carried out by a
re-integration agency, specialized in RTW coaching for CSs.
The coaches from this re-integration agency also conducted
the introductory interviews. These coaches were generally ex-
cancer patients who had experience with cancer survivorship
and job loss, and who had received training to become a
specialized coach in the area of cancer and RTW. The
‘Preparation for RTW’ part of the program took place in the
participant’s home or at an office of the re-integration
agency nearby.
All meetings with the re-integration coaches and job
hunting agency personnel were individual face-to-face meet-
ings. All the available routes in the intervention program are
shortly described below. The full content of the tailored RTW
program was previously published as part of the study proto-
col [13].
Route 1:
The coach and participant decided that the participant
was ready to RTW. The coach then contacted the researchers
to randomly assign the participant to one of the two job
hunting agencies. The selected job hunting agency invited
the participant for a meeting to explore job opportunities.
The job hunting agency was required to find at least two
suitable jobs that matched with participants work profile or
wishes for RTW. Further, employment had to be offered for
at least three months, and should have been either paid
employment, or work with therapeutic conditions and
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Figure 1. The tailored RTW program.
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ongoing benefits. According to protocol, the job hunting
agencies should have found these jobs within four weeks
after the first meeting with the participant. When the job
hunting agency was unable to meet these requirements, the
second job hunting agency involved in this study joined the
search for jobs.
Route 2:
The coach and participant decided that the participant
was not yet ready to start looking for a job, but that (s)he
first needed preparation for RTW. In the following weeks, the
participant and coach created a work profile. The work pro-
file was based on an extensive inventory of the participants’
wishes and needs for RTW, and on the participants’ working
experience and capabilities. Alongside this process, the par-
ticipant received coaching on themes that the participant
and the coach selected together. There were 12 predeter-
mined themes available, and there was also an option to
deviate from these themes if necessary. Examples of themes
that were used in the coaching were: ‘Fatigue and managing
energy levels and RTW’, ‘Communication about cancer at
work’ and ‘Stress, fluctuations in work ability and managing
work, private life and recovery’. After completing the work
profile and participating in four sessions of coaching, the par-
ticipant and coach reevaluated whether the participant was
ready to RTW (Route 2A or Route 2B).
Route 2A: The participant was ready to RTW. In this case,
the coach would contact the researchers, after which a job
hunter was assigned to organize a meeting with the partici-
pant and to start looking for workplaces that would fit the
work profile that was created. This route is similar to Route 1
and is therefore described in more detail in the aforemen-
tioned paragraph ‘Route 1’.
Route 2B: It was decided that the participant needed
more preparation for RTW. Therefore, the participant
received additional sessions of coaching on chosen themes.
This process is essentially the same as the process described
in Route 2, with the exception that the work profile was
already completed at this stage. After participating in add-
itional sessions of coaching, the coach and participant
reevaluated if the participant was ready to RTW (Route 3A
or Route 3B).
Route 3A: The participant was ready to RTW. In this case,
the coach would contact the researchers, after which a job
hunter was assigned to organize a meeting with the partici-
pant and to start looking for workplaces that would fit the
work profile that was created. This route is similar to Route 1
and is therefore described in more detail in the aforemen-
tioned paragraph ‘Route 1’.
Route 3B: If the participant was not ready to RTW
after receiving the full ‘Preparation for RTW’ part of the
program, the intervention program was terminated and
the participant’s case was referred to usual care for fol-
low-up.
The maximum duration of the ‘Preparation for RTW’ part
was three months. The maximum duration of the ‘RTW’ part
was also three months. Further, one-month delay was
allowed within the whole program to allow for unforeseen
events, such as illnesses or holidays. Therefore, the maximum
duration of the RTW program was seven months.
Outcome measures and prognostic factors
The primary outcome measure of this study was duration
until sustainable RTW. This was calculated as the number of
days between the day of inclusion and the first day of sus-
tainable RTW. Sustainable RTW was defined as a period of at
least 28 calendar days, during which the participant was
working. Work could be paid employment, but also work
resumption with ongoing benefits was considered, i.e., thera-
peutic work. The secondary outcome measures were: rate of
RTW, defined as the proportion of participants in the inter-
vention and the control group that returned to work, fatigue
(assessed with the FACIT-Fatigue Scale (Version 4) [14]), qual-
ity of life (assessed with the European Organization for
Research and Treatment of Cancer Quality of Life
Questionnaire (EORTC QLQ C-30 version 3.0) [15]), and par-
ticipation in society (assessed with the Utrecht Scale for
Evaluation of Revalidation and Participation (USER-P), (three
scales: frequency, restrictions, satisfaction) [16] after one year
of follow-up.
Both register data and self-reported data were used to
determine duration until sustainable RTW and rate of RTW in
this study. Data regarding sustainable RTW in paid employ-
ment were obtained from SSA registries. In addition, data
regarding sustainable RTW in therapeutic work were
obtained from self-report, collected using online and paper
questionnaires (depending on the participants’ preference).
Participants in the RCT were asked to complete extensive
questionnaires at baseline (T0), after three (T1), six (T2), and
12 months (T3) follow-up.
Sample size and statistical analysis
The calculated sample size for this study was 130 partici-
pants, based on a power of (1-b)¼ 0.80, a two-sided signifi-
cance level of 0.05 (a). We aimed to include 164
participants, as we anticipated a 20% loss-to-follow-up rate
during the study [13]. The entry of the self-reported data
from the paper questionnaires was checked by performing
a secondary data-entry of 5% of the paper questionnaires
at each measurement point, i.e., T0, T1, T2 and T3. The
maximum percentage of error allowed between the two
data entries was 3%.
To verify the SSA-register data regarding duration until sus-
tainable RTW in paid employment, we compared the register
data with the self-reported data from the follow-up question-
naires. In case of conflicts between the register data and self-
reported data, the register data were considered valid.
Duration until sustainable RTW in therapeutic work was deter-
mined based on the self-reported data, as this type of employ-
ment is not registered at the SSA. In case that multiple dates
of therapeutic work were reported by the participant, the date
reported in the first follow-up questionnaire was used, in
order to minimize recall bias. In this study, RTW in both paid
employment and therapeutic work were considered as sus-
tainable RTW. Therefore, one variable was computed based on
the participants’ inclusion date in the study and the first date
of sustainable RTW, i.e., ‘duration until sustainable RTW’. Also,
this variable was used to calculate the rate of RTW in the
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intervention and control group. Further, scores on validated
questionnaires for non-RTW outcome measures and parame-
ters, e.g., fatigue, quality of life, and participation in society,
were calculated according to the required algorithms. No
measures of imputation were used.
Descriptive analyses, t-tests and v2-tests were used to
describe potential differences in characteristics between the
intervention and control group. All p-values reported are
the results of two-sided tests. The primary outcome meas-
ure, i.e., duration until sustainable RTW, was first assessed
using Kaplan-Meier estimators and the log rank test.
Second, Cox regression analysis was used to estimate haz-
ard ratios (HRs) for duration until sustainable RTW. All anal-
yses were performed according to the intention-to-treat
principle, and carried out on the level of the individual.
Additionally, the per-protocol principle was applied in two
separate analyses, to correct for participants in the inter-
vention group who did not receive the intervention as
intended. In the first per-protocol analysis, all persons in
the intervention group who did not actually start with the
RTW program were removed from analysis. In the second
per-protocol analysis, all persons in the intervention group
who did not receive the intervention according to protocol
were removed from analysis, based on the results of a pre-
viously conducted process evaluation alongside the RCT
(unpub. obs.).
The following confounders were taken into account in the
analyses: age, gender, level of education, marital status, eth-
nicity, time between date of cancer diagnosis and inclusion
in the study, and time between first day of sick leave and
inclusion in the study. Also, we evaluated if significant differ-
ences in baseline characteristics between the intervention
group and control group were confounders in the Cox
regression analysis. The crude Cox regression model only
contained the main variables of interest: duration until sus-
tainable RTW and intervention/control group. An adjusted
model was constructed by entering potential confounding
variables, using a forward entry selection method. The cutoff
point for relevant confounding was set at>10% change in
the regression coefficient for the dependent variable, with a
p-value of 0.1. Further, we evaluated effect modification by
the strata in which participants were categorized, i.e., type of
previous employment contract, by including interaction
terms (and their corresponding main effects) into the model.
In these analyses, the strata of CSs with a previous temporary
contract and temporary agency contract were combined, as
there were only a few participants (N¼ 11) with a temporary
agency contract. It was tested whether the coefficient of the
interaction term was significantly different from zero, at a p-
value level of 0.05. Regardless of any significant confounding
or effect modification, the final model was adjusted for age,
gender and level of education to facilitate comparison with
other studies.
Finally, regarding the secondary outcome measures, rate
of RTW between the intervention and the control group was
compared using a v2-test. All other secondary outcome
measures, i.e., fatigue, quality of life and participation in soci-
ety, were analyzed using linear regression analyses and
adjusted for age, gender and level of education. SPSS 22.0
was used to perform the analyses [17].
Results
Recruitment and study population
In total, 2757 CSs were invited to participate in the study
from April 2013 to January 2015. Of them, 786 survivors were
interested in participation, of whom 474 met the inclusion
criteria, based on the screening questionnaire. These 474 CSs
were contacted by telephone, of whom 171 were eventually
included in the study (Figure 2). Of these, 85 participants
were randomly assigned to the tailored RTW program and 86
participants were assigned to the control group. No medical
contra-indications for any of the participants were reported
by their general physicians.
Also, 715 survivors responded to the initial invitation by
returning the postcard. Of these, 647 declined to participate
for various reasons. The remaining 68 CSs who returned a
postcard, had indicated that they were interested to partici-
pate, but not at that particular point in time. These CSs
received another invitation to participate in the study at the
date they had indicated on the postcard. The postcard
data were part of an extensive study on factors and motives
associated with (non-)participation, which was published
separately [18].
The mean age of the participants was 48.4 years (SD 8.6).
The majority was female (69%), had children (66%), and had
the Dutch nationality (95%). More than half of the partici-
pants were the principal wage earner of the household
(56%). Breast cancer was the most common diagnosis in this
study population (40%). On average, CSs had worked for 24.1
years (SD 10.1) before being diagnosed with cancer.
The majority of participants had a clear intention to RTW
at baseline (71%) (Table 1). The final questionnaires from
participants were collected in March 2016.
Duration until sustainable RTW
During follow-up, 39 (22.8%) of the 171 included CSs sustain-
ably returned to work. Of these, 21 participated in the inter-
vention group, and 18 in the control group. In Figure 3, the
Kaplan-Meier curves for duration to sustainable RTW are pre-
sented. The log rank test revealed no significant differences
between the curves of the intervention group and the con-
trol group (p¼ 0.642).
The results of the Cox regression analyses are presented
in Table 2. The analyses showed a crude HR for duration until
sustainable RTW of 0.86 for the intervention group, com-
pared to the control group. This indicates that participants in
the intervention group took more time to sustainably RTW
compared to participants in the control group, but this differ-
ence was not statistically significant [p¼ 0.642, 95% confi-
dence interval (CI) 0.46–1.62]. Age, as well as baseline
differences between the groups in levels of fatigue and CSs’
active contemplation of RTW, proved to be relevant con-
founders in the analysis. When adjusting the model for these
confounders, the intervention group had sustainably returned
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to work earlier than the control group (HR 1.11; 95% CI 0.57–
2.19), although this effect was far from statistically significant
(p¼ 0.754). The final model was corrected for age, fatigue,
active contemplation of RTW, and additionally for gender
and level of education (Table 2). We found no effect modifi-
cation by stratum, i.e., type of employment contract prior to
job loss (p¼ 0.390).
The first per-protocol analysis, which included the control
group and participants in the intervention group who had
actually started participation in the program, revealed a
crude HR of 0.75 (95% CI 0.38–1.47; p¼ 0.401). Adjusted for
age, gender, fatigue, active contemplation of RTW, and level
of education, the HR was 1.02 (95% CI 0.49–2.12; p¼ 0.958).
In the second per-protocol analysis, which included the con-
trol group and participants in the intervention group who
had received the whole intervention according to protocol,
the crude HR was 1.32 (95% CI 0.65–2.68; p¼ 0.444), and the
adjusted HR was 1.49 (95% CI 0.70–3.17; p¼ 0.302) (Figure 4).
The per-protocol analyses thus revealed that participants,
who received the intervention program according to proto-
col, had a statistically non-significant improvement in dur-
ation until sustainable RTW compared to participants in the
control group.
Effect of the intervention program on rate of RTW,
health-related outcomes and participation
Regarding rate of RTW, we found no significant difference in
the proportion of CSs that returned to work in the control
and the intervention group after one year of follow-up
(p¼ 0.613). Further, the linear regression analyses showed
that there were no statistically significant differences
between the intervention and control group with regard to
fatigue (p¼ 0.538), quality of life (p¼ 0.940), and participa-
tion in society [i.e., frequency, restrictions, and satisfaction
(p-values ranged from 0.130 to 0.953)] (Table 3).
Discussion
Main findings
The hypothesis that was tested in this study was that offer-
ing a tailored return to work program to CSs with job loss
would lead to a significant improvement in duration until
RTW in these CSs, compared to the usual care provided by
the SSA. The main finding of this study is that this hypothesis
is false, i.e., we found no significant differences in duration
until sustainable RTW between CSs with job loss in the inter-
vention group, who received the tailored RTW program, and
those in the control group, who received usual care. Further,
there were no significant differences regarding the secondary
outcome measures, i.e., rate of RTW, fatigue, quality of life,
and participation in society.
Interpretation of findings
The present study offered a multidisciplinary intervention
program to CSs with job loss, but found no statistically sig-
nificant effect on duration until sustainable RTW. A process
evaluation conducted alongside the present RCT showed that
the RTW program was only moderately implemented, and
that less than half of the participants in the intervention
group received the program according to protocol (unpub.
obs.). As the per-protocol analyses showed that CSs who had
received the intervention program according to protocol had
85 Intervention
group
86 Control group
647 declined
68 wanted a new invitation later
183 received baseline questionnaire + IC
T1 response: 76
312 excluded
2757 cancer survivors invited
786 returned screening questionnaire*
474 received telephone call
715 returned postcard
1284 no response
291 excluded
12 no response
40 no response
171 Inclusion and randomization according to
strata
T3 response: 58
T2 response: 65
T1 response: 76
T2 response: 69
T3 response: 64
Figure 2. Participant recruitment flow diagram.
*786 CSs returned the screening questionnaire: 758 CSs returned the questionnaire after
receiving the invitation, and 28 CSs returned it later on, after receiving another invitation
by their own request.
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Table 1. Characteristics of the study population.
Participants (N¼ 171)
Intervention group
(N¼ 85) Control group (N¼ 86)
Variable Categories Mean (SD) Mean (SD) Mean (SD) p-Value*
Age in years 48.4 (8.6) 47.9 (8.5) 48.8 (8.7) 0.492
Total number of years
working
24.1 (10.1) 23.5 (10.1) 24.6 (10.2) 0.502
N (%)† N (%)† N (%)†
Gender Male 53 (31.0) 24 (28.2) 29 (33.7) 0.438
Female 118 (69.0) 61 (71.8) 57 (66.3)
Type of contract before
sick leave
Temporary contract or tem-
porary agency work
96 (56.1) 47 (55.3) 49 (57.0) 0.825
No contract (unemployed) 75 (43.9) 38 (44.7) 37 (43.0)
Level of education None/primary/lower voca-
tional education
30 (17.5) 12 (14.1) 18 (20.9) 0.198
Secondary school 28 (16.4) 18 (21.2) 10 (11.6)
Vocational education/upper
secondary school
60 (35.1) 32 (37.6) 28 (32.6)
Upper vocational education/
university
53 (31.0) 23 (27.1) 30 (34.9)
Principal wage earner No 74 (43.3) 39 (45.9) 35 (41.2) 0.536
Yes 96 (56.1) 46 (54.1) 50 (58.8)
Marital status Living alone 36 (21.1) 17 (20.5) 19 (22.1) 0.776
Married 81 (47.4) 43 (51.8) 38 (44.2)
Living together 28 (16.4) 12 (14.5) 16 (18.6)
Divorced/widowed 24 (14.0) 11 (13.3) 13 (15.1)
Having children No 59 (34.5) 30 (35.3) 29 (33.7) 0.829
Yes 112 (65.5) 55 (64.7) 57 (66.3)
Ethnicity Dutch 163 (95.3) 77 (90.6) 86 (100) 0.004
Non-Dutch 8 (4.7) 8 (9.4) 0 (0.0)
Tumor type Breast 68 (39.8) 30 (44.1) 38 (55.9) 0.235
Lung 3 (1.8) 1 (33.3) 2 (66.7) 0.567
Gynecological 7 (4.1) 4 (57.1) 3 (42.9) 0.688
Colon 13 (7.6) 10 (76.9) 3 (23.1) 0.041
Gastro-intestinal 10 (5.8) 6 (60.0) 4 (40.0) 0.502
Head and neck 8 (4.7) 2 (25.0) 6 (75.0) 0.152
Prostate 3 (1.8) 2 (66.7) 1 (33.3) 0.553
Hematological 23 (13.5) 12 (52.5) 11 (47.8) 0.799
Brain 8 (4.7) 1 (12.5) 7 (87.5) 0.031
Other type of cancer 24 (14.0) 14 (58.3) 10 (41.7) 0.362
Cancer recurrence 4 (2.3) 3 (75.0) 1 (25.0) 0.306
Treatment modalities No treatment 2 (1.2) 2 (100.0) 0 (0.0) 0.152
Surgery 124 (72.5) 64 (51.6) 60 (48.4) 0.418
Radiotherapy 84 (49.1) 32 (38.1) 52 (61.9) 0.003
Chemotherapy 109 (63.7) 52 (47.7) 57 (52.3) 0.488
Hormone therapy 47 (27.5) 19 (40.4) 28 (59.6) 0.135
Immunotherapy 13 (7.6) 8 (61.5) 5 (38.5) 0.375
Other type of treatment 13 (7.6) 7 (53.8) 6 (46.2) 0.756
Type of previous employ-
ment contract
Fixed employment 49 (29.3) 25 (51.0) 24 (49.0) 0.995
Temporary employment 95 (56.9) 47 (49.5) 48 (50.5)
Temporary agency work 21 (12.6) 10 (47.6) 11 (52.4)
Other type of contract 2 (1.2) 1 (50.0) 1 (50.0)
Intention to RTW Uncertain or no intention to
RTW
49 (28.7) 23 (46.9) 26 (53.1) 0.646
Clear intention to RTW 122 (71.3) 62 (50.8) 60 (49.2)
Fatigue Health-related
quality of life (levels of
functioning)
(0–52) 33.0 (9.8) 31.2 (9.6) 34.8 (9.8) 0.017
Quality of life (0–100) 63.7 (17.3) 63.9 (18.1) 63.6 (16.6) 0.894
Physical functioning(0–100) 78.8 (14.8) 77.6 (15.1) 80.0 (14.5) 0.316
Emotional functioning
(0–100)
64.1 (25.0) 64.4 (23.7) 63.9 (26.4) 0.885
Social functioning (0–100) 69.0 (26.0) 68.8 (27.4) 69.2 (24.6) 0.928
Cognitive functioning (0–100) 66.5 (26.9) 66.3 (25.3) 66.7 (28.5) 0.924
Role functioning (0–100) 63.1 (26.4) 63.5 (27.5) 62.6 (25.4) 0.818
Sleeping problems (0–100) 37.8 (33.8) 41.2 (33.4) 33.7 (33.9) 0.113
Financial problems (0–100) 40.6 (35.6) 42.4 (38.3) 38.8 (32.9) 0.520
Participation in daily
activities
Frequency of participation
(0–100)
32.1 (8.2) 31.2 (9.0) 32.9 (7.3) 0.156
Restrictions in participation
(0–100)
81.8 (13.8) 80.2 (14.8) 83.3 (12.6) 0.139
Satisfaction with participation
(0–100)
63.5 (15.2) 63.5 (15.1) 63.5 (15.4) 0.994
*p-Values are the result of t-tests and v2-tests comparing the intervention and control group;
†N and calculated percentages may approach or exceed the total N and 100% because of missing values or rounding differences.
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sustainably returned to work faster than the control group,
although not statistically significant, it could be that imple-
mentation failure in this study contributed to the lack of sig-
nificant results regarding the effectiveness of the RTW
program. When comparing our results to other studies, a
recent Cochrane review showed that, so far, there is moder-
ate, but conflicting evidence that multidisciplinary interven-
tions for CSs have a positive effect on RTW [19]. That is, a
few studies in that review found a significant effect on RTW,
while other studies found no effect at all. To illustrate, a
study in 1983 by Maguire et al. (1983) offered a multidiscip-
linary program to CSs, and found significant improvement
with regard to RTW [20]. Also, Van Waart et al. (2015) found
a significant effect of two physical activity programs on the
rate of RTW, compared to usual care in breast cancer patients
receiving adjuvant chemotherapy, although RTW was not the
main outcome of that study, and the study was not aimed at
CSs with job loss [21]. In contrast, in other studies no effect
of interventions programs on RTW was found. For instance, a
recent study by Tamminga et al. (2013), which offered a hos-
pital-based vocational intervention program to CSs,
demonstrated no effect of the intervention program on RTW
compared to usual care [22]. It should be mentioned that
previous studies were not aimed at CSs with job loss.
Furthermore, in studies conducted in sick-listed workers
with job loss, suffering from a different health condition
than cancer, the evidence regarding the effectiveness of
RTW programs also seems contradictory. To illustrate, a
recent study by Audhoe et al. (2016) found no effect of a
multidisciplinary intervention on RTW or other work-related
outcomes, such as worker participation, in sick-listed work-
ers with psychological problems, who experienced job loss
(unpub. obs.). In contrast, in a study by Vermeulen et al.
(2011), in which a stepped-care participatory RTW program
was offered to sick-listed workers with musculoskeletal dis-
orders who experienced job loss, a significant effect on
RTW was detected [23]. Overall, it may be concluded that
there is a general lack of convincing evidence of RTW
interventions in sick-listed workers who experienced job
loss, both those with cancer and those with another health
condition.
Further, the number of CSs that returned to work in the
present study was only 22.8%. Across earlier studies in CSs,
although not specifically in those with job loss, the rate of
RTW was approximately 62% at one-year post diagnosis, 73%
at one-and-a-half years after diagnosis and 89% at two-years
post diagnosis [6]. It seems that the rate of RTW in the pre-
sent study was quite low, especially given the fact that CSs
in this study were already one year on sick leave at baseline.
First, it should be considered that the population in the pre-
sent study may have suffered from health problems that hin-
dered their RTW. That is, CSs in this study could only
participate if they received sickness or disability benefits at
baseline, indicating the presence of health problems and/or
disabilities in these survivors. In fact, many survivors in the
present study, i.e., those who were on sick leave for 12
months, had been reevaluated for sickness benefits just
before study entry. In addition, the process evaluation con-
ducted alongside the RCT confirmed that health problems
were an important reason for CSs to drop out of the inter-
vention program (unpub. obs.). Overall, it is therefore likely
that CSs in this study were suffering from health problems
that may have reduced their ability to (return to) work, which
Table 2. Results from the Cox regression analysis for duration until sustainable RTW (N¼ 171).
Crude model Adjusted model Final model
HR 95% CI p† HR 95% CI p† HR 95% CI p†
Intervention group‡ 0.86 0.46–1.62 0.642 1.11 0.57–2.19 0.754 1.16 0.59–2.31 0.663
Age 0.92 0.89–0.95 <0.001 0.93 0.90–0.96 <0.001
Fatigue 1.05 1.01–1.08 0.009 1.05 1.01–1.08 0.007
Readiness to RTW contemplation phase 0.84 0.72–0.98 0.028 0.85 0.72–0.99 0.042
Gender 0.63 0.30–1.36 0.633
Level of education**
Secondary school 0.51 0.12–2.14 0.359
Vocational education/upper secondary school 1.31 0.50–3.47 0.582
Upper vocational education/university 0.86 0.29–2.53 0.787
HR: hazard ratio.
†p-Value;
‡compared to the control group;
**compared to the reference group ‘none/primary/lower vocational education’.
Figure 3. Kaplan-Meier curves for duration until sustainable RTW, intention-to-
treat analysis.
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may partly explain the low rate of RTW in the present study,
compared to other studies among CSs.
Other explanations for the discrepancy in RTW rates
between our study and other studies with CSs on sick leave
are that previous experimental studies mostly included CSs
who still had an employer [19]. As workplace- and employer-
related factors, such as workplace accommodation and sup-
port from the workplace, are strongly associated with posi-
tive RTW outcomes [24], higher RTW rates may be more
likely for populations of CSs with an employer, compared to
a population of CSs with job loss. It should also be recog-
nized that during the study period there was an economic
recession in Europe and in the Netherlands [25], which is
likely to have contributed to the low RTW rate in the present
study.
Finally, the present study showed no effect of the tailored
RTW program on fatigue, quality of life, and participation in
society. In other RTW studies for CSs, although not specific-
ally for CSs with job loss, the findings on health-related out-
comes are, at best, ambiguous. That is, the study by
Tamminga et al. (2013) found no significant effect of their
RTW program on quality of life [22]. However, the study by
Van Waart et al. (2015) showed improvements in physical
functioning and reduction of symptoms, such as fatigue [21].
However, it should be considered that this study offered a
program that was primarily aimed at improving physical fit-
ness, and not RTW, which may make it more likely to find an
effect on physical outcomes compared to studies that have
RTW as a primary aim. In conclusion, it seems that multidis-
ciplinary intervention programs for CSs, both those with and
without job loss, show conflicting results regarding RTW out-
comes, as well as regarding health-related outcomes.
Strengths and limitations
The strengths of this study are that the tailored RTW pro-
gram was offered in a nation-wide randomized controlled
setting, and that the analysis of the primary outcome meas-
ure was based on 100% complete follow-up data, as both
register data and self-reported data were used. Also, the cal-
culated sample size required for this study was 131, and
eventually 171 participants were included in the study. There
are also several limitations to this study. First, only a small
portion, i.e., 6% of the invited CSs eventually participated in
the study. Therefore, selection bias is a real probability in this
study, which limits the generalizability of our results. Another
limitation is that we did not measure whether or not partici-
pants in the control group received comparable interventions
as part of their usual care. Finally, our results should be inter-
preted in the context of a national social security system.
Translation of these results to countries with a different social
security context should be done cautiously.
Implications for research and practice
This study provides several key points for researchers and prac-
titioners who are involved in the RTW process of CSs with job
loss. First, given the lack of conclusive evidence of the effect-
iveness of RTW programs in populations of sick-listed workers
with job loss, it would be worthwhile for future researchers to
identify potential causes of theory, program and/or implemen-
tation failure in previous RTW studies. Specifically, researchers
could compare the results of previously conducted experimen-
tal and observational RTW studies, as well as process evalua-
tions conducted alongside previous RCTs for workers with job
loss, suffering from cancer or other health conditions.
Comparing studies conducted in workers within a social secur-
ity context may provide new insights into potential theory and
implementation failure of RTW interventions for workers who
experienced job loss. This could lay the groundwork for
improvements in future interventions to support RTW in work-
ers with job loss, with cancer or with another health condition.
Further, we recommend a critical evaluation of implementa-
tion methods of future intervention programs in complex set-
tings. Specifically, procedures regarding communication and
cooperation between the stakeholders involved in intervention
studies for workers with job loss, such as a SSA, healthcare pro-
fessionals, (future) employers, re-integration agencies and job
hunting agencies, should be discussed and agreed upon
before the start of an intervention program. In addition, for
future studies offering RTW interventions to sick-listed workers
with job loss, it would be beneficial to conduct a pilot study
and/or to include a test phase in a RCT, in order to facilitate
proper implementation on a larger scale later on. Practitioners
could potentially be consulted in order to enhance
Figure 4. Kaplan-Meier curves for duration until sustainable RTW, per-protocol
analysis.
Table 3. Results of the analyses on secondary outcome measures* (N¼ 122).
Secondary outcome measure Beta 95% CI p†
Fatigue 1.253 5.275–2.770 0.538
Quality of life 0.284 7.117–7.684 0.940
Frequency of participation 2.591 5.961–0.778 0.130
Restrictions in participation 0.718 4.695–6.131 0.793
Satisfaction with participation 0.194 6.308–6.696 0.953
*Results for the intervention group compared to the control group, adjusted
for age, gender, and level of education;
†p-value.
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implementation strategies for future programs, in order to
bridge the gap between research and daily practice.
Conclusion
The tailored RTW program for CSs with job loss that was
offered in this study did not result in a significant improve-
ment in duration until sustainable RTW, compared to usual
care. Considering that the number of CSs with job loss is
expected to increase in the future, it is essential to identify
new methods of work support for these survivors. As there is
still inconclusive evidence with regard to the effectiveness of
current RTW programs for CSs with job loss, and for workers
with other health conditions who experienced job loss, it is
important to gain more knowledge on suitable intervention
strategies for these populations of workers.
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